- 101. BCNU/CDDP/CTX/G-CSF
- (UMLS (NCI) C0280917) =Therapeutic or Preventive Procedure
| - 136. BCNU/DOX/IFN-A/PRED/VCR
- (UMLS (NCI) C0338173) =Therapeutic or Preventive Procedure
|
- 102. BCNU/CDDP/DTIC
- (UMLS (NCI) C0280646) =Therapeutic or Preventive Procedure
| - 137. BCNU/DOX/PRED/VCR
- (UMLS (NCI) C0078139) =Therapeutic or Preventive Procedure
|
- 103. BCNU/CDDP/DTIC/IFN-A/IL-2/TMX
- (UMLS (NCI) C0338192) =Therapeutic or Preventive Procedure ;
| - 138. BCNU/DTIC/HU
- (UMLS (NCI) C0279252) =Therapeutic or Preventive Procedure ;
|
- 104. BCNU/CDDP/DTIC/IFN-A/TMX
- (UMLS (NCI) C0338137) =Therapeutic or Preventive Procedure
| - 139. BCNU/DTIC/HU/VCR
- (UMLS (NCI) C0279253) =Therapeutic or Preventive Procedure ;
|
- 105. BCNU/CDDP/DTIC/IL-2/TMX
- (UMLS (NCI) C0279124) =Therapeutic or Preventive Procedure
| - 140. BCNU/DTIC/TDR
- (UMLS (NCI) C0281492) =Therapeutic or Preventive Procedure
|
- 106. BCNU/CDDP/DTIC/TMX
- [A regimen consisting of tamoxifen, cisplatin, dacarbazine and carmustine used to treat advanced-stage or metastatic malignant melanoma. ( NCI )] (UMLS (NCI) C0914674) Carmustine/Cisplatin/Dacarbazine/Tamoxifen;
Dacarbazine-Cisplatin-Carmustine-Tamoxifen Regimen;
Dartmouth Regimen;
DTIC-Cisplatin-BCNU-Tamoxifen Regimen =Therapeutic or Preventive Procedure | - 141. BCNU/IFN-A
- (UMLS (NCI) C0338123) =Therapeutic or Preventive Procedure ;
|
- 107. BCNU/CDDP/TSPA
- (UMLS (NCI) C0281356) =Therapeutic or Preventive Procedure
| - 142. BCNU/IFN-A/TMX
- (UMLS (NCI) C0338358) =Therapeutic or Preventive Procedure ;
|
- 108. BCNU/CDDP/VP-16
- (UMLS (NCI) C0278710) =Therapeutic or Preventive Procedure
| - 143. BCNU/L-PAM
- (UMLS (NCI) C0796301) Carmustine/Melphalan =Therapeutic or Preventive Procedure ;
|
- 109. BCNU/CPT-11
- (UMLS (NCI) C0393059) =Therapeutic or Preventive Procedure
| - 144. BCNU/MP
- (UMLS (NCI) C0280064) =Therapeutic or Preventive Procedure
|
- 110. BCNU/CTX/DACT/DOX/MP/MTX/PRED/VCR
- (UMLS (NCI) C0278896) =Therapeutic or Preventive Procedure
| - 145. BCNU/MTX
- (UMLS (NCI) C0280687) =Therapeutic or Preventive Procedure
|
- 111. BCNU/CTX/DACT/MP/MTX/PRED/VCR
- (UMLS (NCI) C0280730) =Therapeutic or Preventive Procedure ;
| - 146. BCNU/MTX/PCB
- (UMLS (NCI) C0279266) =Therapeutic or Preventive Procedure
|
- 112. BCNU/CTX/DM
- (UMLS (NCI) C0280059) =Therapeutic or Preventive Procedure
| - 147. BCNU/NIMO/VCR
- (UMLS (NCI) C0280814) =Therapeutic or Preventive Procedure ;
|
- 113. BCNU/CTX/DOX/L-PAM
- (UMLS (NCI) C0165053) =Therapeutic or Preventive Procedure ;
| - 148. BCNU/PCB/VCR
- (UMLS (NCI) C0279258) =Therapeutic or Preventive Procedure
|
- 114. BCNU/CTX/DOX/L-PAM/PRED/VCR
- (UMLS (NCI) C0280128) =Therapeutic or Preventive Procedure
| - 149. BCNU/TCAR
- (UMLS (NCI) C0280708) =Therapeutic or Preventive Procedure
|
- 115. BCNU/CTX/G-CSF/TSPA
- (UMLS (NCI) C0393043) =Therapeutic or Preventive Procedure
| - 150. BCNU/TDR
- (UMLS (NCI) C0279201) =Therapeutic or Preventive Procedure
|
- 116. BCNU/CTX/G-CSF/VP-16
- (UMLS (NCI) C0280670) =Therapeutic or Preventive Procedure
| - 151. BCNU/TMZ
- (UMLS (NCI) C0281737) =Therapeutic or Preventive Procedure
|
- 117. BCNU/CTX/HU/VP-16
- (UMLS (NCI) C0297110) =Therapeutic or Preventive Procedure ;
| - 152. BCNU/TOPO
- (UMLS (NCI) C0393058) =Therapeutic or Preventive Procedure
|
- 118. BCNU/CTX/IFN-A/L-PAM/PRED/VCR
- (UMLS (NCI) C0338128) =Therapeutic or Preventive Procedure ;
| - 153. BCNU/TSPA/VP-16
- (UMLS (NCI) C0280831) =Therapeutic or Preventive Procedure
|
- 119. BCNU/CTX/IFN-A/VP-16
- (UMLS (NCI) C0338182) =Therapeutic or Preventive Procedure
| - 154. BCNU/TZT
- (UMLS (NCI) C0279417) =Therapeutic or Preventive Procedure
|
- 120. BCNU/CTX/L-PAM/MNI/PRED
- (UMLS (NCI) C0280676) =Therapeutic or Preventive Procedure
| - 155. BCNU/VCR
- (UMLS (NCI) C0280813) =Therapeutic or Preventive Procedure ;
|
- 121. BCNU/CTX/L-PAM/PRED
- (UMLS (NCI) C0279375) =Therapeutic or Preventive Procedure
| - 156. BCNU/VP-16
- (UMLS (NCI) C0338287) =Therapeutic or Preventive Procedure ;
|
- 122. BCNU/CTX/L-PAM/PRED/VCR
- (UMLS (NCI) C0065442) =Therapeutic or Preventive Procedure
| - 157. BCPR
- [This gene is involved in tumor suppression. ( NCI )] (UMLS (NCI) C1332403) BCPR Gene;
Breast Cancer-Related Regulator of TP53 Gene;
=Gene or Genome ;
◊ [Encoded by human BCPR Gene, BCPR Protein appears to be associated with expression of p53, perhaps regulating its expression. Lesions of BCPR seem to be involved in most breast cancers. (from OMIM and NCI) ( NCI )] (UMLS (NCI) C1332404) BCPR Protein; Breast Cancer-Related Regulator of TP53; Breast Cancer-Related Regulator of TP53 Protein Amino Acid, Peptide, or Protein; Biologically Active Substance |
- 123. BCNU/CTX/L-PAM/VP-16
- (UMLS (NCI) C0281439) =Therapeutic or Preventive Procedure
| - 158. BCR
- [This gene plays a role in signal transduction. ( NCI )] (UMLS (NCI) C0812385) BCR Gene;
Breakpoint Cluster Region Gene =Gene or Genome ;
|
- 124. BCNU/CTX/Mesna/VP-16
- (UMLS (NCI) C0393025) =Therapeutic or Preventive Procedure
| - 159. BCR ABL Fusion Protein
- [An onco-protein generated from the fusion of Bcr and Abl genes by translocation process between chromosome 9 and 22 (Philadelphia chromosome), in CML (P210) and some ALL (P190). Aberrant expression of BCR-ABL in bone marrow cells results in a variety of leukemias. ( NCI )] (UMLS (NCI) C0004891) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
|
- 125. BCNU/CTX/PCB/PRED/VBL
- (UMLS (NCI) C0054326) =Therapeutic or Preventive Procedure
| - 160. BCR Downstream Signaling 1
- [BCR Downstream Signaling 1, encoded by BRDG1 gene, functions as a docking protein acting downstream of Tec tyrosine kinase in B cell antigen receptor signaling. This protein is directly phosphorylated by Tec in vitro where it participates in a positive feedback loop, increasing Tec activity. A mouse ortholog, stem cell adaptor protein 1, shares 83% identity with its human counterpart. It has a proline-rich region, a pleckstrin homology domain and SH2 domain. (From LocusLink, Swiss_Prot and NCI) ( NCI )] (UMLS (NCI) C1332405) BRDG1;
Docking protein BRDG1;
STAP-1 =Amino Acid, Peptide, or Protein; Biologically Active Substance |
- 126. BCNU/CTX/PRED
- (UMLS (NCI) C0053051) =Therapeutic or Preventive Procedure ;
| - 161. BCR Downstream Signaling 1 Gene
- [This gene is involved in signal transduction and protein trafficking. It also plays a role in the immune response. ( NCI )] (UMLS (NCI) C1332447) BRDG1;
BRDG1 Gene;
=Gene or Genome ;
|
- 127. BCNU/CTX/PRED/VCR
- (UMLS (NCI) C0053054) =Therapeutic or Preventive Procedure ;
| - 162. BCR-ABL Peptide Vaccine
- [A multivalent antineoplastic vaccine comprised of the bcr-abl oncogene breakpoint fusion peptide that elicits a bcr-abl specific T-cell immune response. (NCI04) ( NCI )] (UMLS (NCI) C0879331) bcr-abl vaccine =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Immunologic Factor
|
- 128. BCNU/CTX/TSPA
- (UMLS (NCI) C0280435) =Therapeutic or Preventive Procedure ;
| - 163. Bcr-Abl Peptide Vaccine/QS21
- (UMLS (NCI) C0879334) =Therapeutic or Preventive Procedure
|
- 129. BCNU/CTX/TSPA/VCR
- (UMLS (NCI) C0279415) =Therapeutic or Preventive Procedure
| - 164. BCRG2
- [Widely expressed by human WDR22 Gene, the function of WD Repeat Domain Protein 22 is unknown. (NCI) ( NCI )] (UMLS (NCI) C1336985) BCRP2;
Breakpoint Cluster Region Protein 2;
WD Repeat Domain Protein 22;
WD Repeat-Containing Protein 22;
WDR22;
=Amino Acid, Peptide, or Protein; Biologically Active Substance |
- 130. BCNU/CTX/VP-16
- (UMLS (NCI) C0054917) =Therapeutic or Preventive Procedure
| - 165. BCSC-1
- [BCSC-1, encoded by the LOH11CR2A gene, is a predicted 438-amino acid protein. The LOH11CR2A coding region is composed of 10 exons and spans 30 to 40 kb. There are at least 2 additional exons encoding the 5-prime untranslated region. LOH11CR2A is expressed ubiquitously as a 3.3-kb mRNA. BCSC-1 is a putative tumor suppressor, but unlikely to be involved in the tumorigenic process. (from LocusLink and OMIM) ( NCI )] (UMLS (NCI) C1332406) Breast Cancer Suppressor Candidate 1;
LOH11CR2A;
Loss of Heterozygosity 11 Chromosomal Region 2 Gene A Protein =Amino Acid, Peptide, or Protein; Biologically Active Substance |
- 131. BCNU/DAVA/DOX/PRED
- (UMLS (NCI) C0058894) =Therapeutic or Preventive Procedure ;
| - 166. BCSFB (blood cerebrospinal fluid barrier)
- [ ] (UMLS (CSP) C0234562) =Organ or Tissue Function
|
- 132. BCNU/DBD
- (UMLS (NCI) C0281689) =Therapeutic or Preventive Procedure
| - 167. BCT
- [An operation to remove the breast cancer but not the breast itself. Types of breast-conserving surgery include lumpectomy (removal of the lump), quadrantectomy (removal of one quarter of the breast), and segmental mastectomy (removal of the cancer as well as some of the breast tissue around the tumor and the lining over the chest muscles below the tumor). ( NCI )] (UMLS (NCI) C0917927) Breast Conservation Treatment;
breast-conserving surgery =Therapeutic or Preventive Procedure ;
|
- 133. BCNU/dFdC/L-PAM
- (UMLS (NCI) C0796322) Carmustine/Gemcitabine/Melphalan;
=Therapeutic or Preventive Procedure | - 168. BCX-1777
- (UMLS (NCI) C1175653) =Organic Chemical; Pharmacologic Substance
|
- 134. BCNU/DM/DOX/L-PAM/VCR
- (UMLS (NCI) C0078138) =Therapeutic or Preventive Procedure
| - 169. BCX-34
- (UMLS (NCI) C0535443) =Nucleic Acid, Nucleoside, or Nucleotide; Pharmacologic Substance
|
- 135. BCNU/DOX/5-FU
- (UMLS (NCI) C0059994) =Therapeutic or Preventive Procedure ;
| |
home
